Tyrberg, Tobias http://orcid.org/0000-0003-4594-9976
Nilsson, Staffan
Blennow, Kaj
Zetterberg, Henrik
Grahn, Anna
Funding for this research was provided by:
Sveriges Kommuner och Landsting (#ALFGBG-588341, #ALFGBG-715986, #ALFGBG-720931)
Vetenskapsrådet (#2017-00915, #2018-02532)
Hjärnfonden (#FO2017-0243)
H2020 European Research Council (#681712)
Article History
Received: 14 January 2020
Revised: 14 January 2020
Accepted: 29 July 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: KB has served as a consultant or at advisory boards for Axon, Biogen, CogRx, Lilly, MagQu, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper. HZ has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed and CogRx; has given lectures in symposia sponsored by Biogen and Alzecure; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all outside submitted work). The other authors declare that they have no conflict of interest.